MAURICE FLEMMING: Open Payments
NPI 1063540177 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 13 payments from 10 companies in 2025. Trend: 2023 $751 · 2024 $431 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $120 |
| Exact Sciences Corporation | 1 | $120 |
| Dexcom, Inc. | 2 | $50 |
| PROTEGA PHARMACEUTIALS INC | 3 | $46 |
| Gilead Sciences, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: AREXVY, The Cologuard Plus Collection Kit, Dexcom G6 Transmitter, ROXYBOND, PREVNAR 20, MOUNJARO, Omnipod, Rybelsus.
Industry payments across MO — which companies pay providers there.
